T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia
J Laurence - Annals of internal medicine, 1993 - acpjournals.org
Purpose: To update our knowledge about normal absolute values for CD4+ and CD8+
peripheral T-lymphocyte subsets and to show how these values are influenced by infectious …
peripheral T-lymphocyte subsets and to show how these values are influenced by infectious …
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
Objective: The objective of this study is to estimate life expectancies of HIV-positive patients
conditional on response to antiretroviral therapy (ART). Methods: Patients aged more than …
conditional on response to antiretroviral therapy (ART). Methods: Patients aged more than …
Idiopathic CD4 lymphocytopenia
UA Walker, K Warnatz - Current opinion in rheumatology, 2006 - journals.lww.com
The manifestation of opportunistic infections calls for the evaluation of the immune system
for CD4 lymphocytopenia. The differential diagnosis of this condition in adults comprises …
for CD4 lymphocytopenia. The differential diagnosis of this condition in adults comprises …
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy
Background The relationship between the timing of the initiation of antiretroviral therapy
(ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of …
(ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of …
Gender effect on in vitro lymphocyte subset levels of healthy individuals
Differences in gender immune response have resulted in differences in immune protection
and susceptibility to inflammatory diseases. Cultured peripheral blood mononuclear cells …
and susceptibility to inflammatory diseases. Cultured peripheral blood mononuclear cells …
The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model
W Hao, A Friedman - PloS one, 2014 - journals.plos.org
Atherosclerosis, the leading death in the United State, is a disease in which a plaque builds
up inside the arteries. As the plaque continues to grow, the shear force of the blood flow …
up inside the arteries. As the plaque continues to grow, the shear force of the blood flow …
B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome
M Colucci, R Carsetti, S Cascioli… - Journal of the …, 2016 - journals.lww.com
The pathogenesis of nephrotic syndrome is unclear. However, the efficacy of rituximab, a B
cell–depleting antibody, in nephrotic syndrome suggests a pathogenic role of B cells. In this …
cell–depleting antibody, in nephrotic syndrome suggests a pathogenic role of B cells. In this …
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
NM Archin, NK Vaidya, JAD Kuruc… - Proceedings of the …, 2012 - National Acad Sciences
HIV type 1 (HIV-1) persists within resting CD4+ T cells despite antiretroviral therapy (ART).
To better understand the kinetics by which resting cell infection (RCI) is established, we …
To better understand the kinetics by which resting cell infection (RCI) is established, we …
Population-based hematologic and immunologic reference values for a healthy Ugandan population
ES Lugada, J Mermin, F Kaharuza… - Clinical and Vaccine …, 2004 - Am Soc Microbiol
To assess the validity of the reference values for hematologic and immunologic indices
currently used in Africa, we evaluated blood samples from 3,311 human immunodeficiency …
currently used in Africa, we evaluated blood samples from 3,311 human immunodeficiency …
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
A Mocroft, P Reiss, J Gasiorowski… - JAIDS Journal of …, 2010 - journals.lww.com
Background: Little is known about the incidence and risk factors for serious non-AIDS-
defining events. Methods: The incidence of non-AIDS events (malignancies, end-stage renal …
defining events. Methods: The incidence of non-AIDS events (malignancies, end-stage renal …